Search results
Found 9295 matches for
New collaboration will help researchers understand why cancer survival between patients differs
27 January 2020
NDORMS researchers join five other universities to investigate how cancer survivors make antibodies that target and destroy tumours, and explore routes for new treatments
New therapeutic target identified in spondyloarthritis
20 January 2020
A new study published in Nature Communications identifies a key driver of joint and intestinal inflammation that could lead to future treatment of the chronic inflammatory disease.
Cancer progression may be controlled by targeting tumor-specific extracellular matrix
15 January 2020
Researchers have uncovered how tumors exploit tenascin-C to deflect the body’s natural defence against them.
Researchers identify link in the treatment of inflammatory bowel disease (IBD)
6 December 2019
A new study published in the Journal of Experimental Medicine reveals how IL-10 and PGE2 work together to prevent inflammatory tissue damage and maintain a healthy gut balance
NDORMS team awarded the International Dupuytren Award
Awards
12 November 2019
Jagdeep Nanchahal, Professor of Hand, Plastic and Reconstructive Surgery at the Kennedy Institute, and his team have won the International Dupuytren Award for a trial repurposing anti-TNF in Dupuytren’s disease.
Dissecting TNF signalling in inflammatory disease
28 October 2019
New research from Dr Richard Williams’ group at the Kennedy Institute suggests a route for the development of more selective – and effective – therapies for immune-mediated inflammatory disease.
NDORMS careers event: transitioning from postdoc to PI
23 October 2019
A careers event held by NDORMS offered information and advice to postdoctoral researchers transitioning to becoming independent group leaders.
Synthetic cells capture and reveal hidden messages of the immune system
17 September 2019
When immune cells detect harmful pathogens or cancer, they mobilise and coordinate a competent defence response. To do this effectively immune cells must communicate in a way that is tailored to the pathogenic insult. Consequently, the body's response to various health challenges depends on successful coordination among the cells of the immune system.
Naturally occurring compound spermidine boosts vaccine responses in old mice
30 August 2019
Researchers at the Kennedy Institute identify a molecular pathway to boost vaccine responses in the elderly.
Kennedy researchers join UK inflammatory arthritis research centre
21 August 2019
Oxford is the newest partner of the national Research into Inflammatory Arthritis Centre Versus Arthritis (RACE) which has been awarded continued funding of nearly £2m over the next five years from Versus Arthritis.
Study links blood vessels to therapy resistance in cancer metastasis to bone
15 July 2019
A new study from the Kennedy Institute of Rheumatology reveals a role for blood vessels in promoting therapy resistance of cancer metastasis in bone.
Kennedy Trust renews commitment to rheumatology research with £20M
Funding
2 July 2019
The Kennedy Trust for Rheumatology Research (KTRR) has pledged a minimum of £20M over five years to the Kennedy Institute of Rheumatology at the University of Oxford to support pioneering research into chronic inflammatory disease.
Bringing patients closer to arthritis research
7 June 2019
The Kennedy Institute recently hosted a visit from the National Rheumatoid Arthritis Society (NRAS) to explore opportunities to partner on patient involvement approaches in arthritis research.
Kennedy researchers awarded MRC funding for arthritis research
Funding
5 June 2019
Congratulations to Kennedy researchers Professor Chris Buckley, Professor Mark Coles and Dr Stephen Sansom who have been awarded £1.5M funding from the Medical Research Council (MRC) to explore fibroblasts as an emerging target to treat chronic inflammatory disease.
Key link discovered between tissue cell type and different forms of arthritis
30 May 2019
Pioneering research by scientists at the Universities of Oxford and Birmingham published today in Nature brings us a step closer to developing targeted therapies for inflammatory diseases.
Study reveals new drug target for rheumatoid arthritis
28 May 2019
New research at the Kennedy Institute reveals potential of a novel class of drugs for the treatment of rheumatoid arthritis.
UKRI Future Leaders Fellowship to Dr Fiona Watt
Awards
7 May 2019
Dr Fiona Watt has been awarded a prestigious UK Research and Innovation (UKRI) Future Leaders Fellowship to further her research for better treatments for people living with, or at risk of the commonest form of arthritis, osteoarthritis.
Progress in targeting inflammatory disease in the gut and skin
18 April 2019
Two articles from the Kennedy Institute review the latest in understanding immune control in the gut and skin and explain how this knowledge is being translated into new treatments for inflammatory disease
2019 NDORMS Imaging Symposium and Awards
29 March 2019
Oxford researchers gathered at the Kennedy Institute earlier this month to learn how advanced imaging technologies, such as super resolution microscopy, are pushing the boundaries of scientific discovery.
Showcasing a new approach to arthritis research
27 March 2019
A recent workshop at Pembroke College, Oxford, provided a showcase for research within the Arthritis Therapy Acceleration Programme (A-TAP) aimed at speeding up the delivery of new drugs for immune-mediated inflammatory disease (IMIDs).